Literature DB >> 9041370

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.

M Levi1, T van der Poll, H ten Cate, S J van Deventer.   

Abstract

Disseminated intravascular coagulation (DIC) is a frequently occurring complication of sepsis and may contribute to multiple organ failure. More insight into the pathogenesis of this derangement of the coagulation system is necessary to develop more effective therapeutic strategies for this condition. Recently, more detailed knowledge on the pathogenetic pathways involved in DIC has been obtained by the study of models of experimental bacteraemia and endotoxaemia in human subjects and non-human primates. The mechanisms that lead to activation of coagulation, potentiated by the simultaneous depression of physiological inhibitory systems and to impaired function of the fibrinolytic system, are outlined in this review. In addition, the mediatory role of various cytokines in the derangement of coagulation is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041370     DOI: 10.1046/j.1365-2362.1997.570614.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  58 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

3.  Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction?

Authors:  Sükrü Oter; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2006-09-30       Impact factor: 17.440

4.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

5.  Protective effect of exogenous 70-kDa heat shock protein during endotoxic shock (sepsis).

Authors:  G A Kustanova; A N Murashev; I V Guzhova; B A Margulis; I R Prokhorenko; S V Grachev; M B Evgen'ev
Journal:  Dokl Biol Sci       Date:  2006 Nov-Dec

6.  Plasma derived protein C in severe sepsis: report of two cases.

Authors:  A Tuttolomondo; A Pinto; D Di Raimondo; P Fernandez; G Licata
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

Review 7.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

8.  Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.

Authors:  Offer Erez; Roberto Romer; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Ricardo Gomez; Eli Maymon; Percy Pacora; Samuel S Edwin; Chong Jai Kim; Nandor Gabor Than; Pooja Mittal; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

9.  Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Authors:  Amanda Hurley; Mindy Smith; Tatiana Karpova; Rebecca B Hasley; Natalya Belkina; Stephen Shaw; Nariman Balenga; Kirk M Druey; Erin Nickel; Beverly Packard; Hiromi Imamichi; Zonghui Hu; Dean Follmann; James McNally; Jeanette Higgins; Michael Sneller; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

Review 10.  Polyphosphate and omptins: novel bacterial procoagulant agents.

Authors:  Thomas H Yun; James H Morrissey
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.